Humanized anti-CD20 antibodies and methods of use

Details for Australian Patent Application No. 2010214082 (hide)

Owner Biolex Therapeutics, Inc.

Inventors Williams, David G.

Agent Spruson & Ferguson

Pub. Number AU-A-2010214082

PCT Pub. Number WO2010/093480

Priority 61/152,778 16.02.09 US; 61/153,499 18.02.09 US

Filing date 16 February 2010

Wipo publication date 19 August 2010

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/093480 Priority application(s): WO2010/093480

6 September 2012 Assignment before Grant

  Biolex Therapeutics, Inc. The application has been assigned to Synthon Biopharmaceuticals B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214085-Systems, methods and apparatus relating to generation, transmission, access and storage of virtual white line (VWL) images and data for excavation projects

2010214066-Management system for providing visibility, quality control and audit capability for underground facility locating and marking operations